WELL Health Subsidiary WELLSTAR Gets Conditional TSX Venture Listing Approval

Key Facts

1WELL Health subsidiary WELLSTAR received conditional approval to list as a Tier 1 issuer on the TSX Venture Exchange.

2WELLSTAR shares are expected to commence trading under the ticker WSTR on or around October 1, 2026.

WELLSTAR Technologies Corp, a subsidiary of WELL Health Technologies Corp, received conditional approval to list as a Tier 1 issuer on the TSX Venture Exchange. Newsfile Corp reported that WELLSTAR shares are expected to commence trading under the ticker WSTR on or around October 1, 2026. The listing follows a corporate amalgamation transaction designed to separately list the digital health subsidiary.

The spin-off is intended to unlock shareholder value and provide a distinct valuation benchmark for the parent company's healthcare technology assets. According to company statements, 30,296,464 of the resulting subordinate voting shares will be subject to voluntary lock-up arrangements, with a total of 77,223,308 shares expected to be issued and outstanding following the consolidation.